APMI

DPMS - Pharma

Investment Approach Details

₹0.00

(AUM CR)

PMS Provider Name

Klay Securities Private Limited

Benchmark

S&P BSE 500 TRI

Strategy Name

Equity

Product Name

Equity

Date Of Inception

24/11/2021

Age

3.11 Years

Min. Inv. Amount

5000000

Fixed Fees Structure

Management Fees: 2%

Variable Fees Structure

Hurdle Rate: 8% Profit Sharing: 20%

Exit Load

1st Year: 3% 2nd Year: 2% 3rd Year: 1%

Purpose

Creating significant value over long term by investing in a concentrated portfolio of Indian Pharma and Healthcare Sector by investing in securities which are significantly below fair value and with strong long-term prospects.

Fund Manager Details


IAN DSOUZA
Work Exp. NA
Email ID ian@klaycapital.in
Mobile No NA
Details NA

Period-Wise Performance

IA vs. Benchmark Performance

Turnover Details As On 31/10/2024

1 Month Turnover

0.00

1 Year Turnover

0.56